Real-world effectiveness of remdesivir in immunocompromised patients hospitalized due to SARS-CoV-2 Infection: Insights to inform pharmacy practice.
Saved in:
| Title: | Real-world effectiveness of remdesivir in immunocompromised patients hospitalized due to SARS-CoV-2 Infection: Insights to inform pharmacy practice. |
|---|---|
| Authors: | Kalil AC; Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Chima-Melton C; Cardiopulmonary Division, Pipeline Health, Los Angeles, CA.; Tele-ICU Inc., Los Angeles, CA, USA., Naslazi E; Evidence and Access, Certara, The Netherlands., Ramroth H; Medical Affairs, Gilead Sciences, Foster City, CA, USA., Amin AN; Department of Medicine, School of Medicine, University of California Irvine, Irvine, CA, USA., Pettit NN; Department of Pharmacy, UChicago Medicine, Chicago, IL, USA., Gottlieb RL; Department of Internal Medicine, Baylor University Medical Center, Baylor Scott & White Health, Dallas, TX.; Burnett School of Medicine at TCU, Fort Worth, TX, USA. |
| Source: | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2026 Apr 11; Vol. 83 (Supplement_3), pp. S2931-S2939. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Internet ISSN: 1535-2900 (Electronic) Linking ISSN: 10792082 NLM ISO Abbreviation: Am J Health Syst Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1535-2900 |
|---|---|
| DOI: | 10.1093/ajhp/zxag036 |
